http://rdf.ncbi.nlm.nih.gov/pubchem/author/MD5_679c5cccfd16c5599f07b34179023027
Outgoing Links
Predicate | Object |
---|---|
family-name | Oliveira |
name | Carla Oliveira |
given-name | Carla |
organization-name | Nuclear Medicine-Radiopharmacology, Champalimaud Clinical Center, Champalimaud Foundation, Lisbon, Portugal CEB-Centre of Biological Engineering, University of Minho, Campus de Gualtar, 4710-057, Braga, Portugal. carlaoliveira@deb.uminho.pt. Institute of Molecular Pathology and Immunology of the University of Porto; and Faculty of Medicine, University of Porto, Porto, Portugal IBB—Ins. for Biotechnology and Bioengineering Centre of Biological Engineering, Universidade do Minho Campus de Gualtar 4710‐057 Braga Portugal REQUIMTE, Serviço de Bromatologia, Faculdade de Farmácia da Universidade do Porto, Rua Anibal Cunha 164, 4099-030 Porto, Portugal Institute of Molecular Pathology and Immunology of the University of Porto (IPATIMUP), Porto, Portugal; Expression Regulation in Cancer, Instituto de Investigação e Inovação em Saúde (i3S), University of Porto, Porto, Portugal; Department of Pathology, Faculty of Medicine, University of Porto, Porto, Portugal Departamento de Biologia Molecular, Instituto de Ciência Biomédicas de Abel Salazar (ICBAS), Universidade do Porto, Porto, Portugal Institute of Molecular Pathology and Immunology and Medical Faculty; University of Porto; Porto Portugal Expression Regulation in Cancer Group, IPATIMUP–Institute of Molecular Pathology and Immunology of the University of Porto, Porto, Portugal26Faculty of Medicine, University of Porto, Porto, Portugal Giovanni Corso, Daniele Marrelli, and Franco Roviello, University of Siena and Instituto Toscano Tumori; Carla Vindigni, Azienda Ospedaliera Universitaria Senese, Siena, Italy; Giovanni Corso, Joana Carvalho, Raquel Seruca, and Carla Oliveira, Institute of Molecular Pathology and Immunology of the University of Porto (IPATIMUP); Giovanni Corso, Joana Carvalho, Raquel Seruca, and Carla Oliveira, University of Porto, Portugal; Beatriz Carvalho, VU University Medical Center, Amsterdam, the Netherlands. Head of Expression Regulation in Cancer Group, Porto, Portugal i3S – Instituto de Investigação e Inovação em Saúde, Universidade do Porto, Porto, Portugal; Ipatimup – Institute of Molecular Pathology and Immunology of the University of Porto, Porto, Portugal Department of Pathology and Oncology, Faculty of Medicine, University of Porto, 4200-319 Porto, Portugal Universidade Católica Portuguesa, CBQF - Centro de Biotecnologia e Química Fina - Laboratório Associado, Escola Superior de Biotecnologia, Rua Diogo Botelho, Porto, Portugal. Expression Regulation in Cancer, Institute of Molecular Pathology and Immunology, University of Porto (IPATIMUP), Porto, Portugal; Instituto de Investigação e Inovação em Saúde, University of Porto, Porto, Portugal; Dept. of Pathology, Faculty of Medicine, University of Porto, Porto, Portugal i3S—Instituto de Investigação e Inovação em Saúde Universidade do Porto Rua Alfredo Allen 208 4200‐135 Porto Portugal; Ipatimup—Institute of Molecular Pathology and Immunology University of Porto Rua Júlio Amaral de Carvalho 45 4200‐135 Porto Portugal; Department Pathology and Oncology Faculty of Medicine University of Porto Alameda Prof. Hernâni Monteiro 4200‐319 Porto Portugal Department of Medical Sciences, Institute of Biomedicine – iBiMED, University of Aveiro , 3810-193 Aveiro, Portugal i3S Instituto de Investigação e Inovação em Saúde University of Porto INEB – Instituto de Engenharia Biomédica Porto Portugal Department of Pathology and Oncology Faculty of Medicine University of Porto Porto Portugal; Instituto de Investigação e Inovação em Saúde Universidade do Porto Porto Portugal; Expression Regulation in Cancer Institute of Molecular Pathology and Immunology of the University of Porto (IPATIMUP) Porto Portugal IPATIMUP - Institute of Molecular Pathology and Immunology of the University of Porto, Instituto de Investigação e Inovação em Saúde, Universidade do Porto, Porto, Portugal Escola Superior de Biotecnologia, Universidade Católica Portuguesa, Rua Dr. Bernardino de Almeida, 4200-072 Porto, Portugal Institute of Molecular Pathology and Immunology of the University of Porto (IPATIMUP), Porto, Portugal Institute of Molecular Pathology and Immunology, The University of Porto, IPATIMUP, 4200-465 Porto, Portugal. i3S – Instituto de Investigação e Inovação em Saúde, Universidade do Porto, Porto, Portugal;; IPATIMUP – Instituto de Patologia e Imunologia Molecular da Universidade do Porto, Porto, Portugal; Santo António Hospital Porto University Hospital Centre Porto Portugal Expression Regulation in Cancer Group, Institute of Molecular Pathology and Immunology of the University of Porto (IPATIMUP), Porto, Portugal. Centre of Biological Engineering University of Minho Campus de Gualtar 4710‐057 Braga Portugal From the Assistance Publique-Hôpitaux de Paris (AP-HP), Hôpital Saint-Antoine, Service d'Anatomie Pathologique; Université Pierre et Marie Curie-Paris; Institut National de la Santé et de la Recherche Médicale, U762, Centre d’Etude du Polymorphisme Humain; AP-HP, Hôpital Lariboisière, Service central d'Anatomie et Cytologie Pathologiques; AP-HP, Hôpital Saint-Antoine, Service de Gastroentérologie et Nutrition; AP-HP, Hôpital Saint-Antoine, Service de Chirurgie Viscérale, Paris; Service d'Anatomie... Expression Regulation in Cancer Group Instituto de Investigação e Inovação em Saúde (i3S) Porto Portugal; Institute of Molecular Pathology and Immunology of the University of Porto (IPATIMUP) Porto Portugal; Department of Pathology and Oncology Faculty of Medicine University of Porto Porto Portugal Instituto de Investigação e Inovação em Saúde (i3S); Universidade do Porto; Portugal; Expression Regulation in Cancer Group; Institute of Molecular Pathology and Immunology of the University of Porto (IPATIMUP); Portugal; Departamento de Patologia e Oncologia, Faculdade de Medicina; Universidade do Porto; Portugal Department of Pathology, University of Porto, Porto, Portugal. Hospital S. João, Porto, Portugal REQUIMTE, Serviço de Bromatologia, Faculdade de Farmácia da Universidade do Porto, Rua Anibal Cunha 164, 4050-047 Porto, Portugal Institute for Biotechnology and Bioengineering (IBB), Centre of Biological Engineering, University of Minho, Campus de Gualtar, 4710-057 Braga, Portugal Department of Pathology FMUP Porto Portugal; Institute of Molecular Pathology and Immunology at the University of Porto (Ipatimup) Porto Portugal; Institute for Research Innovation in Health (i3S) University of Porto Porto Portugal i3S, Instituto de Investigação e Inovação em Saúde, Universidade do Porto, Rua Alfredo Allen 208, 4200-135 Porto, Portugal; IPATIMUP, Institute of Molecular Pathology and Immunology of University of Porto, Rua Alfredo Allen 208, 4200-135 Porto, Portugal; Department of Pathology, Faculty of Medicine of University of Porto, 4200-319 Porto, Portugal Escola Superior de Biotecnologia, Universidade Católica Portuguesa, Rua Dr. António Bernardino de Almeida, 4200-072 Porto, Portugal; ADVID (Associação para o Desenvolvimento da Viticultura Duriense), Rua José Vasques Osório 62, 5 apartado 137, 5050-280 Peso da Régua, Portugal; and Direcção Regional de Agricultura de Tras-os-Montes, Rua da Républica 133, 5370-347 Mirandela, Portugal Gastroenterology Department, Hospital Garcia de Orta, Almada, Portugal CBQF – Centro de Biotecnologia e Química Fina – Laboratório Associado, Escola Superior de Biotecnologia Universidade Católica Portuguesa Porto Portugal Graduate Program in Medicine: Medical Sciences Universidade Federal do Rio Grande do Sul 90035‐003 Porto Alegre Brazil; Pain Pharmacology and Animal Models of Neuromodulation Laboratory Department of Pharmacology Institute of Basic Health Sciences Universidade Federal do Rio Grande do Sul 90050‐170 Porto Alegre Brazil; Animal Experimentation Unit Hospital de Clínicas de Porto Alegre Graduate Research Group 90035‐003 Porto Alegre Brazil INEB—Instituto de Engenharia Biomédica, Universidade do Porto, Porto, Portugal.; Instituto de Saúde Pública, Universidade do Porto, Porto, Portugal. |
Incoming Links
Total number of triples: 264.